Login / Signup

Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis.

Ayinalem AlemuZebenay Workneh BitewGetu DiribaEmebet GashuGetachew SeidKirubel EshetuAbebaw KebedeBalako Gumi
Published in: BMJ open (2023)
CRD42022371014.
Keyphrases
  • drug resistant
  • multidrug resistant
  • acinetobacter baumannii
  • mycobacterium tuberculosis
  • randomized controlled trial
  • risk factors
  • hiv infected
  • human immunodeficiency virus
  • antiretroviral therapy